Modification Platforms for Protein Therapeutics
Exhibitor: CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT
Booth No: N416
Characteristic
The modifications of protein therapeutics can be used to improve their activity, solubility, thermostability, and immunogenicity. The market of protein therapeutics modification is approximately US$3 billion with an annual growth rate of 12%, highlighting its importance. Three platforms, including the incorporation of disulfide bond, PROTEINylation, and PEGylation, were developed by our team. We aim to assist academia and the biotechnology industry by improving the stability and solubility of protein therapeutics in the developmental stage.
Other Products
-
Antithrombotic Drug with Low Risk of Bleeding
-
Fibrin and Platelet-targeting Thrombolytic Drug
-
Bispecific Drugs for Cancers
-
Anti-fibrotic Drug Targeting ECM
-
Protein Production and GLP Laboratory
Highest Rated Products
-
WINMAPᵀᴹ
-
DS MAPs
-
WINMAP™ Mini
-
Power Patch
-
V Patch
-
Vaccine Microarray Patches
-
Pneumatic Liquid Filling Machine
-
Powder Machine-High Speed Mixer / Granulator
-
Planetary Vacuum Mixer
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
2ton Mixing and Melting Tank with Storage Tanks
-
High Speed Mixing Machine
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
UV-Visible Spectrophotometer
-
Cell Function Assay Kit(Apoptosis/Cycle/Proliferation/Cytotoxicity/Viability)
-
Biostatistical Analysis
-
Data Management
-
CM30 Incubation Monitoring System
-
CURIOSIS Celloger Nano
-
CDMO services
-
DISCOVERY Comfort Pipettor
-
LTS Style Pipette Tips
-
Rotary Evaporator
-
Centrifugal Evaporator (Teflon coated)
-
Clinical Small Centrifuges
-
High Performance Liquid Chromatography, HPLC
-
Risk Assessment
